Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women. [electronic resource]
Producer: 20160517Description: 507-13 p. digitalISSN:- 2040-2058
- Adult
- Atazanavir Sulfate -- adverse effects
- CD4 Lymphocyte Count
- Cross-Sectional Studies
- Drug Administration Schedule
- Drug Combinations
- Female
- HIV Protease Inhibitors -- adverse effects
- HIV-1 -- drug effects
- Humans
- Hyperbilirubinemia -- chemically induced
- Infant, Newborn
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Ritonavir -- adverse effects
- Viral Load -- drug effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.